Annual Operating Margin
-6060.24%
NaN%
December 31, 2023
Summary
- As of February 7, 2025, CYCC annual operating profit margin is -6060.24%
- CYCC annual operating margin is now -82440.22% below its all-time high of 7.36%, reached on January 1, 1994.
Performance
CYCC Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Margin
-21.77 K%
+69.33 K%+76.10%
September 30, 2024
Summary
- As of February 7, 2025, CYCC quarterly operating profit margin is -21.77 thousand%, with the most recent change of +69.33 thousand% (+76.10%) on September 30, 2024.
- Over the past year, CYCC quarterly operating margin has dropped by -4479.68% (-25.91%).
- CYCC quarterly operating margin is now -4223.26% below its all-time high of 527.98%, reached on December 31, 2010.
Performance
CYCC Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Margin Formula
Operating Profit Margin = Operating Profit
Revenue ✕ 100%
Revenue ✕ 100%
CYCC Operating Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -25.9% |
| 3 y3 years | - | - |
| 5 y5 years | +4.8% | - |
CYCC Operating Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -1269.6% | +76.1% |
| 5 y | 5-year | at high | at low | -1269.6% | +76.1% |
| alltime | all time | <-9999.0% | +90.8% | -4223.3% | +76.6% |
Cyclacel Pharmaceuticals Operating Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -21.77 K%(-76.1%) |
| Jun 2024 | - | -91.10 K%(+506.6%) |
| Mar 2024 | - | -15.02 K%(-13.1%) |
| Dec 2023 | -6060.24%(-4.8%) | -17.29 K%(-59.6%) |
| Sep 2023 | - | -42.78 K%(+2591.4%) |
| Jun 2023 | - | -1589.54%(-3.3%) |
| Dec 2018 | -6365.33%(+279.2%) | -1643.33%(+43.6%) |
| Dec 2016 | -1678.53%(+101.8%) | -1144.04%(-32.5%) |
| Sep 2016 | - | -1696.10%(+0.1%) |
| Jun 2016 | - | -1693.69%(-37.1%) |
| Mar 2016 | - | -2693.53%(+193.7%) |
| Dec 2015 | -831.79%(-35.7%) | -917.10%(+93.2%) |
| Sep 2015 | - | -474.69%(-61.2%) |
| Jun 2015 | - | -1221.96%(+18.1%) |
| Mar 2015 | - | -1034.77%(-55.8%) |
| Dec 2014 | -1293.94%(-22.0%) | -2340.89%(+203.4%) |
| Sep 2014 | - | -771.43%(-50.7%) |
| Jun 2014 | - | -1566.01%(+14.6%) |
| Mar 2014 | - | -1366.16%(+2.8%) |
| Dec 2013 | -1658.12%(-92.4%) | -1329.10%(-29.1%) |
| Sep 2013 | - | -1875.40%(+19.2%) |
| Jun 2013 | - | -1573.48%(-17.7%) |
| Mar 2013 | - | -1910.85%(-97.9%) |
| Dec 2012 | -21.89 K%(+62.0%) | -93.08 K%(+904.3%) |
| Sep 2012 | - | -9268.42%(-36.8%) |
| Jun 2012 | - | -14.66 K%(+548.7%) |
| Jun 2011 | - | -2260.12%(-9.6%) |
| Mar 2011 | - | -2500.00%(-573.5%) |
| Dec 2010 | -13.51 K%(+586.3%) | 527.98%(-121.0%) |
| Sep 2010 | - | -2514.47%(-31.8%) |
| Jun 2010 | - | -3685.71%(+124.4%) |
| Mar 2010 | - | -1642.44%(-28.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | -1969.05%(-48.9%) | -2306.42%(+50.9%) |
| Sep 2009 | - | -1528.26%(-16.9%) |
| Jun 2009 | - | -1839.85%(-19.6%) |
| Mar 2009 | - | -2287.28%(+735.7%) |
| Dec 2008 | -3851.20%(-84.0%) | -273.71%(-94.5%) |
| Sep 2008 | - | -4997.40%(-8.5%) |
| Jun 2008 | - | -5458.89%(-0.2%) |
| Mar 2008 | - | -5470.06%(-93.6%) |
| Dec 2007 | -24.02 K%(+180.5%) | -86.13 K%(+309.6%) |
| Sep 2007 | - | -21.03 K%(+0.7%) |
| Jun 2007 | - | -20.88 K%(+65.6%) |
| Mar 2007 | - | -12.61 K%(+118.4%) |
| Dec 2006 | -8562.53%(+46.7%) | -5773.50%(-26.1%) |
| Sep 2006 | - | -7815.66%(-65.4%) |
| Jun 2006 | - | -22.57 K%(+189.7%) |
| Mar 2006 | - | -7793.38%(+2.7%) |
| Dec 2005 | -5835.67%(-86.4%) | -7585.71%(+220.9%) |
| Sep 2005 | - | -2363.52%(-70.2%) |
| Jun 2005 | - | -7930.99%(-26.9%) |
| Mar 2005 | - | -10.85 K%(-81.9%) |
| Dec 2004 | -42.76 K%(+307.5%) | -59.91 K%(+13.5%) |
| Sep 2004 | - | -52.78 K%(+106.8%) |
| Jun 2004 | - | -25.52 K%(-46.6%) |
| Mar 2004 | - | -47.81 K%(+151.2%) |
| Dec 2003 | -10.49 K%(-84.2%) | -19.03 K%(+253.7%) |
| Sep 2003 | - | -5380.82%(-40.2%) |
| Jun 2003 | - | -9001.69%(-69.5%) |
| Mar 2003 | - | -29.54 K% |
| Dec 2001 | -66.25 K%(+378.7%) | - |
| Dec 2000 | -13.84 K%(<-9900.0%) | - |
| Jan 1994 | 7.36%(+21.3%) | - |
| Jan 1993 | 6.07% | - |
FAQ
- What is Cyclacel Pharmaceuticals annual operating profit margin?
- What is the all time high annual operating margin for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals quarterly operating profit margin?
- What is the all time high quarterly operating margin for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals quarterly operating margin year-on-year change?
What is Cyclacel Pharmaceuticals annual operating profit margin?
The current annual operating margin of CYCC is -6060.24%
What is the all time high annual operating margin for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high annual operating profit margin is 7.36%
What is Cyclacel Pharmaceuticals quarterly operating profit margin?
The current quarterly operating margin of CYCC is -21.77 K%
What is the all time high quarterly operating margin for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high quarterly operating profit margin is 527.98%
What is Cyclacel Pharmaceuticals quarterly operating margin year-on-year change?
Over the past year, CYCC quarterly operating profit margin has changed by -4479.68% (-25.91%)